Best in 7 days Home BPC-157 Calculator: Dose, Units, mL & Reconstitution Guide US$ 28.34 Sold : Login>>
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines US$ 22.42 Min. order: 1 piece ★★★★★ 4.1 (233 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 27.71 Min. order: 1 piece ★★★★★ 4.5 (165 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.44 Min. order: 1 piece ★★★★★ 4.1 (139 reviews) Sold : Login>>
You thought Ozempic was big? Just wait. The next generation of weight-loss medications is already in clinical trials — oral pills, monthly injections, and even triple-action drugs that may work better than US$ 21.82 Min. order: 1 piece ★★★★★ 4.8 (134 reviews) Sold : Login>>
Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept - Bhattachar - 2026 - Diabetes, Obesity and Metabolism US$ 26.16 Min. order: 1 piece ★★★★★ 4.0 (257 reviews) Sold : Login>>